THRX

UPDATE 1-Glaxo says "Son of Advair" fares well in trial - 12/02 - 11:32 AM ET

BRIEF-Theravance reports favorable outcome of FDA advisory committee meeting on telavancin - 11/19 - 03:22 PM ET

THRX: Telavancin Receives Favorable Recommendation from FDA Advisory Committee - 11/19 - 03:01 PM ET

Theravance Reports Favorable Outcome of FDA Advisory Committee Meeting on Telavancin for the Treatment of Complicated Skin and Skin Structure Infections - 11/19 - 02:40 PM ET

Trading in Theravance Common Stock Halted - 11/19 - 07:05 AM ET

UPDATE 2-Theravance rises ahead of US drug review - 11/17 - 05:10 PM ET

UPDATE 1-Theravance drug may be related to deaths-FDA staff - 11/17 - 10:55 AM ET

Theravance drug may be related to deaths-FDA staff - 11/17 - 09:52 AM ET

Theravance Announces Posting of Briefing Documents for FDA Anti-Infective Drugs Advisory Committee Meeting on Telavancin - 11/17 - 09:23 AM ET

THRX: To Present At Credit Suisse Healthcare Conference @ 12:00 ET [delayed] - 11/12 - 10:24 AM ET

Theravance to Present at the Credit Suisse Phoenix Healthcare Conference - 11/04 - 04:05 PM ET

Theravance Inc reports employment inducement awards - 11/04 - 07:57 AM ET

Theravance Announces New Employment Inducement Awards - 11/03 - 06:15 PM ET

Theravance Slips On Q3 Loss - 10/24 - 02:51 PM ET

Theravance Reports Third Quarter 2008 Financial Results - 10/23 - 04:05 PM ET

Telavancin Data to Be Presented at Upcoming Scientific Conferences - 10/16 - 04:05 PM ET

BRIEF-Theravance announces FDA advisory committee to review telavancin - 10/14 - 12:05 PM ET

THERAVANCE INC SAYS MEETING IS SCHEDULED FOR NOVEMBER 19 - 10/14 - 12:02 PM ET

Theravance Announces FDA Advisory Committee to Review Telavancin for the Treatment of Complicated Skin and Skin Structure Infections - 10/14 - 11:59 AM ET

Theravance to Report Third Quarter 2008 Financial Results on October 23, 2008 - 10/09 - 04:05 PM ET

Page 1 of 6     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index